Zhida Shen
Impact in
-
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Nanoplatforms for cancer theranostics
Papers in
-
- Angiogenesis and VEGF in Cancer 4
-
- Nanoplatforms for cancer theranostics 3
- Co-authors
- Guosheng Fu (11 shared papers)Jian Ji (2 shared papers)Fan Jia (3 shared papers)Yongyan Deng (1 shared paper)Qiao Jin (1 shared paper)Meihui Wang (7 shared papers)Fuyu Qiu (5 shared papers)Qi Chen (2 shared papers)
- Journals
- Annals of Translational Medicine (2 papers)Nature Communications (1 paper)Oxidative Medicine and Cellular Longevity (1 paper)Cardiovascular Diabetology (1 paper)Biomaterials (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Zhida Shen
26 papers receiving 576 citations
Peers
Comparison fields: 5 of 96
- Cancer Research 99
- Biomedical Engineering 208
- Biomaterials 60
- Geriatrics and Gerontology 12
- Biochemistry 24
Countries citing papers authored by Zhida Shen
This map shows the geographic impact of Zhida Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhida Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhida Shen more than expected).
Fields of papers citing papers by Zhida Shen
This network shows the impact of papers produced by Zhida Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhida Shen. The network helps show where Zhida Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhida Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 228 | |
| 2 | 2019 | 118 | |
| 3 | 2021 | 21 | |
| 4 | 2019 | 21 | |
| 5 | 2020 | 20 | |
| 6 | 2020 | 17 | |
| 7 | 2018 | 17 | |
| 8 | 2021 | 16 | |
| 9 | 2018 | 16 | |
| 10 | Breviscapine attenuatted contrast medium-induced nephropathy via PKC/Akt/MAPK signalling in diabetic mice. | 2016 | 14 |
| 11 | 2019 | 14 | |
| 12 | 2025 | 10 | |
| 13 | 2022 | 9 | |
| 14 | 2019 | 9 | |
| 15 | 2020 | 8 | |
| 16 | 2025 | 7 | |
| 17 | 2021 | 7 | |
| 18 | 2019 | 5 | |
| 19 | 2022 | 4 | |
| 20 | 2015 | 4 |
About Zhida Shen
Zhida Shen is a scholar working on Molecular Biology, Biomedical Engineering, Cardiology and Cardiovascular Medicine, Immunology and Surgery, having authored 26 papers that have together received 580 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), Nanoplatforms for cancer theranostics (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Medical Imaging Techniques and Applications (2 papers), Autophagy in Disease and Therapy (2 papers), Cardiac Fibrosis and Remodeling (2 papers), Acute Kidney Injury Research (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Cancer Research (99 citations), Biomedical Engineering (208 citations), Biomaterials (60 citations), Geriatrics and Gerontology (12 citations) and Biochemistry (24 citations). Zhida Shen has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Guosheng Fu, Jian Ji, Fan Jia, Yongyan Deng, Qiao Jin, Meihui Wang, Fuyu Qiu, Qi Chen, Qinfeng Li and Hao Zheng. Their work appears in journals such as Annals of Translational Medicine, Nature Communications, Oxidative Medicine and Cellular Longevity, Cardiovascular Diabetology and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.